semaglutide 3ml pen 3.0ML Weight Lose Semanext Injection (3ml Cartridge +

Food and Drug Administration has approved semaglutide (Wegovy) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition

A new study muddles the picture.

Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration

In propensity-matched analyses, semaglutide was associated with lower cardiovascular event rates than metformin, DPP-4 inhibitors, and SGLT2 inhibitors

Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any price, a new